FADS1 encodes enzymes that convert omega-3 and omega-6 fatty acids. Variants in FADS1 can alter blood fatty acid profiles, which in turn may influence insulin sensitivity and blood sugar regulation. Some studies (e.g., rs174547) report modest associations with fasting glucose or HbA1c levels. However, the effects are small and modulated by dietary intake of polyunsaturated fats and overall lifestyle. A DNA test alone cannot diagnose diabetes or predict blood sugar. It is best used as a piece of the puzzle alongside measured glucose markers (fasting glucose, HbA1c) and dietary assessment. If values are elevated or risk factors exist, consult a physician. Evidence is human-moderate: replicated associations exist but not strong enough for clinical decisions. MyBody-X tests provide insights, not medical diagnoses.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-435f8181b84d73f3d60c5bf2